Print page Close print preview
Logo Going International
Accedi a banche dati online | Convegnodetail
 

3rd Annual Ligase Targeting Drug Development Summit

Evvnt Promotion / evvnt
Archivio
-
11.04.2023 - 13.04.2023  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
 
Temi della conferenza
From discovery to clinical development, the field of protein degradation is booming with excitement, with a whole host of investments and new companies joining the effort to successfully degrade unwanted or undrugged targets with key roles in a broad range of diseases from oncology to CNS, through to autoimmune.

Despite this, key challenges remain to rapidly and successfully discover novel and underexploited Ubiquitin E3 ligases.
Scientific organizer
Hanson Wade
Annotazioni
Speakers: Kirby Swatek, Principal Investigator, University of Dundee, Ian Churcher, Chief Scientific Officer, Amphista Therapeutics, David Duda, Senior Scientist, Johnson and Johnson and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1450513-2?pid=4832
Mr. Alex Domingo
 
Categorie
Sanità Pubblica (Public Health), Servizi sanitari
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5846.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom